Mutations in the Cu/Zn superoxide dismutase (SOD1) gene cause familial amyotrophic lateral sclerosis (FALS) by gain of an aberrant function that is not yet well understood. The role of Cu 2ϩ in mediating the toxicity of mutant SOD1 has been earnestly contested. We tested the in vivo effects of genetically induced copper deprivation on the ALS phenotype of transgenic mice expressing G86R mutant mouse SOD1, a protein that fails to incorporate Cu 2ϩ in its active site. Genetically copper-deficient SOD1 G86R transgenic mice were produced by mating SOD1 G86R males to female carriers of the X-linked mottled/brindled (Mobr) mutation. We found that the Mobr allele causes a severe (ϳ60%) depletion of spinal cord copper levels; however, despite the burden of double genetic lesions, it lengthens the lives of SOD1 G86R transgenic mice by 9%. These findings provide evidence supporting a role for copper in the pathogenesis of FALS linked to SOD1 mutations.
Introduction
The pathogenic mechanism of amyotrophic lateral sclerosis (ALS)-associated mutant Cu/Zn superoxide dismutase (mSOD1) appears to be a biochemical gain-of-function independent of SOD activity (Reaume et al., 1996; Bruijn et al., 1998) . Inappropriate release of Cu redox activity may play a role in the disease mechanism (Wiedau-Pazos et al., 1996; Nagano et al., 1999) ; however, mSOD1 species possess 0% (e.g., H46R and G85R) to 100% (e.g., G37R) of wild-type SOD activity, suggesting that pathogenicity is not directly related to the activity of Cu at the active site of SOD1 (Borchelt et al., 1994) . Underscoring this, a recent study (Subramaniam et al., 2002) reported that neurodegeneration in transgenic mice overexpressing mutant SOD1 was not rescued by genetic removal of the copper chaperone for SOD1 (CCS), which optimizes the insertion of Cu 2ϩ into the buried active site. Dismutase activity was indeed partially reduced in the CCS Ϫ/Ϫ /mutant SOD1-crossed mice compared with SOD transgenics (Subramaniam et al., 2002) .
We and others have argued that these findings do not allow us to disqualify Cu from the pathogenesis of this disorder (Beckman et al., 2002; Bush, 2002; Valentine and Hart, 2003) . For example, a pro-oxidative interaction between Cu and SOD1 outside of the active site of the protein has not yet been excluded. The pathological Cu-dependent pro-oxidant reactions attributed to SOD1 include peroxidation (Wiedau-Pazos et al., 1996) , peroxynitrite generation (Estevez et al., 1999) , and inappropriate hydrogen peroxide generation (Said Ahmed et al., 2000) . The pro-oxidant activities can be mediated by non-dismutase Cu binding sites on the protein (Bush, 2002; Valentine and Hart, 2003) . Furthermore, recent studies have shown that CCS is not obligatory for the insertion of Cu into SOD1 (Carroll et al., 2004) , and therefore CCS ablation is no longer expected to abolish Cu binding to SOD1. We studied transgenic mice that express mutant SOD1 G86R (Ripps et al., 1995) . SOD1 G86R fails to incorporate Cu into its active site in mouse tissue and in cell culture (Hayward et al., 2002) . This familial ALS (FALS) model expresses a mutation of mouse SOD1 [analogous to the G85R mutation of human SOD1, which also lacks SOD activity (Borchelt et al., 1994) ] and develops rapidly progressive fatal neurodegeneration between the ages of 90 and 120 d (Morrison et al., 1998) . To induce a specific depletion of tissue Cu, we crossed the SOD1 G86R mice with mice carrying the mottled/brindled (Mobr) mutation. This X-linked mutation inhibits the activity of an ATPase that transports Cu 2ϩ across the intestinal lumen. The mutant allele causes severe copper deficiency that can be lethal (Hunt, 1974 ). Here we report that despite the double-mutant lesion, SOD1 G86R transgenic progeny possessing the Mobr allele had improved survival compared with the SOD1 G86R transgenic progeny without the Mobr allele. Therefore, the beneficial effects of lowering cellular Cu levels in this model may be mediated by reduction of copper incorrectly incorporated into mutant SOD1.
Materials and Methods
Transgenic mice. All protocols were conducted within National Institutes of Health guidelines for animal research and were approved by the Institutional Animal Care and Use Committee. C57BL/6 females with mottled/brindled (heterozygous Mobr females, Mobr/XX) (The Jackson Laboratory, Bar Harbor, ME) were bred to C57BL/6 males to produce heterozygous Mobr females. Highly inbred transgenic male FVB/N mice overexpressing mouse SOD1
G86R [now available from The Jackson Laboratory as Stock #005110 FVB-Tg(Sod1-G86R)M1Jwg/J] were crossed with heterozygous Mobr females. Offspring were screened by PCR for the SOD1 G86R transgene as published previously (Ripps et al., 1995) . Screening for the Mobr mutation was performed by examination of the coat color [i.e., males and females with agouti coat color were without the Mobr gene; females expressing the diluted gray pigment characteristic of Mobr mosaicism were identified as heterozygous Mobr females, and males that were uniformly gray were identified as hemizygous Mobr males (Mobr/Y)]. Litters were separated at weaning and maintained until symptoms of neurodegeneration appeared. Animals were observed daily beginning at 85-90 d of age, because our previous work had shown that the SOD1 G86R animals without the Mobr gene develop motor weakness after 90 d. Mice then were followed for progression of symptoms. When clinical examination of the diseased animals determined that they were unable to right themselves or take food or water, death was considered imminent and the animals were killed.
Mobr males (Mobr/Y) on C57BL/6 background are smaller, develop stiffness of the hind limbs as well as hypoactivity, and usually die 2-3 weeks after birth. We found, however, that by crossing C57BL/6 female heterozygotes for Mobr to our SOD1 G86R males in FVB/N background, the hemizygous Mobr male progeny without SOD1 G86R consistently survived for Ͼ6 months. We examined 10 Mobr mice (Mobr/Y) in C57BL/ 6/FVB/N (hybrid) background for 6 months. Mild tremor in their limbs and gray coat color were observed; otherwise they exhibited no major abnormal behaviors or phenotype, and all 10 survived to 6 months. The milder phenotype of the Mobr/Y males on the hybrid C57BL/6/FVB/N may be attributable to partially elevated Cu levels caused by the influence of FVB/N background alleles. The brain Cu levels at 2 weeks of age were ϳ47% higher in C57BL/6/FVB/N hybrid Mobr males (0.995 Ϯ 0.233 g/gm wet weight) than in C57BL/6 Mobr males (0.675 Ϯ 0.120; p Ͻ 0.05).
The ability to produce hemizygous Mobr males that survive long enough to develop the SOD1 G86R -related FALS phenotype, and the capacity to identify the presence of the Mobr gene by simple visual inspection, facilitated an evaluation of genetically induced copper deficiency on the longevity of both male and female mice carrying the SOD1 G86R transgene. Tissue copper measurements. Mice were deeply anesthetized with an equal mixture of ketamine (100 mg/ml) and xylazine (20 mg/ml). The animals were perfused transcardially with cold 0.1 M PBS for 10 min. Brains and spinal cords were removed, weighed, and freeze dried for copper measurement. Tissues were digested overnight at room temperature in 2 ml of concentrated HNO 3 . Partially digested samples were then heated at 90°C on a heating block for 15 min and then allowed to cool for 10 -20 min. An equivalent volume of concentrated H 2 O 2 was added, and effervescence was allowed to subside for 20 -30 min. Digested samples were then heated at 90°C for 15 min and allowed to cool. The completely digested tissues were then diluted in 1% HNO 3 to a concentration approximating 0.2% total dissolved solids in acid-washed tubes. Each tissue sample was then measured by inductively coupled plasma mass spectrometry (Varian Ultramass, Melbourne, Australia) in triplicate and compared with metal standards as described previously (Cherny et al., 2001) .
Histochemistry and immunocytochemistry. Mice were perfused transcardially with cold 0.1 M PBS for 1 min followed by cold 4% paraformaldehyde in PBS for 10 min, and the spinal cords were removed rapidly, blocked coronally, and postfixed in 4% paraformaldehyde in PBS for 6 hr. Blocks were cryoprotected in 30% sucrose for 24 hr and sectioned on a cryostat at 40 m.
Parallel series of sections were collected for immunocytochemistry and Nissl staining (cresyl violet). Tissue sections for single-label immunocytochemistry were incubated overnight at 4°C in polyclonal antibody (rabbit IgG) against glial fibrillary acidic protein (GFAP) diluted to 1:50 in 0.01 M PBS containing 0.3% Triton X-100 and 0.5 mg/ml bovine serum albumin (Biomeda, Foster City, CA). The sections were then processed by the avidin-biotin-peroxidase method with Vectastain ABC kits (Vector Laboratories, Burlingame, CA) and 3,3Ј-diaminobenzidine. Photomicrographs were taken on a Zeiss Axiophot II microscope.
Determination of SOD1 activity and staining. Animals were killed under anesthetic, and brains and spinal cords were dissected out and frozen on dry ice. These tissues were homogenized in 4 vol of 0.05 M potassium phosphate buffer, pH 7.8, followed by brief sonication. Samples were centrifuged for 5 min at 20,000 ϫ g, and then supernatants were stored at Ϫ80°C. SOD activity was assayed by the modification of the method described by Beauchamp and Fridovich (1971) . Briefly, xanthine/xanthine oxidase was used to produce superoxide flux. Nitroblue tetrazolium (NBT) reduction by superoxide radicals to blue formazan was measured at 560 nm in a PerkinElmer Life Sciences (Emeryville, CA) Lambda 40 UV/VIS spectrophotometer at room temperature. The rate of NBT reduction in the absence of tissue was used as the reference rate (0.020 Ϯ 0.005 AU/min). The amount of inhibition was defined as a percentage of the reference rate of NBT reduction. The reaction mixture contained 50 mM potassium phosphate, pH 10.2, 100 M xanthine, 1 mM EDTA, 1 U catalase, 56 M NBT, xanthine oxidase, and tissue sample up to 200 g of protein.
For activity gel analyses, brain and spinal cord tissue homogenates (40 g of total protein) were electrophoresed on 4 -20% gradient nondenaturing polyacrylamide gel and visualized for SOD activity bands according to the modified method of Steinman (1985) . Briefly, the gel was soaked in 20 mM potassium phosphate, pH 7.8, containing 28 M riboflavin and 28 mM EDTA for 15 min, rinsed in water, and then soaked in 2.5 mM NBT for 15 min. The gel was rinsed in water and placed in a dry tray and illuminated with fluorescent light for 5-10 min to generate superoxide radicals. The band in the gel in which SOD is present is depleted of superoxide radicals, unable to reduce the NBT, leaving a white band in the blue background of the gel. Mouse and human SOD1 migrate differently through the gel and can be differentiated. Western blot analysis. Brain and spinal cord tissue homogenates of total protein concentrations were measured by BCA assay (Pierce, Rockford, IL), and 40 g of total protein were electrophoresed on 4 -20% gradient Tris-glycine polyacrylamide gel with SDS in running buffer and loading dye and electrotransferred to a polyvinylidene fluoride membrane (BioRad, Hercules, CA). After transfer, the membranes are blocked and then incubated with primary antibody in blocking buffer for 2-3 hr at room temperature. We used sheep anti-SOD1 antibody (Sigma, St. Louis, MO) or human SOD1-specific antibody (Chemicon, Temecula, CA) as primary antibodies and developed with HRP-conjugated secondary antibody. Some blots were stripped and reprobed with monoclonal antimouse ␤-tubulin antibody (Sigma). Protein bands were developed using a Supersignal West Pico chemiluminescence system (Pierce) with a CDPStar Chemiluminescent Detection System (Applied Biosystems, Foster City, CA).
Statistical analysis. Statistical analysis was performed using the MannWhitney and Kaplan-Meier test for survival measured in postnatal days and Student's t test for copper analysis.
Results

Genetic copper ablation of SOD1
G86R mice We introduced a specific genetic lesion that lowered spinal cord copper levels (the Menkes disease gene) by crossing heterozygous Mobr female mice (on C57BL/6 background) with SOD1 G86R males (on FVB/N background). This generated female and male SOD1 G86R mice possessing the Mobr allele (MobrG86R). Spinal cord copper levels in these progeny were lowered to 35% of the levels in age-matched (3 months old, pooled gender) SOD1 G86R transgenic mice (Fig. 1) . The marked ( p Ͻ 0.001) lowering of tissue copper levels attributable to the Mobr genetic lesion was not caused by background effects because copper levels of SOD1 G86R transgenic mice (FVB/N background) were not significantly different when compared with either age-matched nontransgenic mice on the same background or nontransgenic controls possessing the same hybrid background as the SOD1 G86R mice with the Mobr allele (C57BL/6 ϫ FVB/N) (Fig. 1) .
Increased life span of Mobr/SOD1
G86R double mutants The cross-breeding generated SOD1 G86R mice with and without the Mobr allele, on a hybrid (C57BL/6 ϫ FVB/N) genetic background. Nineteen hemizygous Mobr males with SOD1 G86R were generated and 17 males with SOD1 G86R without Mobr, as well as 14 heterozygous Mobr females with SOD1 G86R and 27 females with SOD1 G86R without Mobr. The Mobr/SOD1 G86R doublemutant mice analyzed in this study have the same hybrid background (C57BL/6 ϫ FVB/N). When the survival data from transgenic males and females was pooled, the mean age at death was 130 Ϯ 11 d for Mobr/SOD1 G86R double mutants (n ϭ 34) but only 120 Ϯ 12 d (n ϭ 44) for SOD1 G86R single mutants ( p Ͻ 0.001) (Fig. 2) . This difference represents a 9% increase in life span for the copper-deficient double-mutant Mobr/SOD1 G86R compared with the nondeficient single-mutant SOD1 G86R mice. There was no significant difference for the mean ages at death between male and female transgenic mice. The double-mutant Mobr/SOD1 G86R animals also lived to longer maxima: 17 animals (50%) lived beyond 130 d to a maximum of 154 d, compared with single-mutant SOD1 G86R mice; only 10 (23%) animals lived for 130 -140 d (Fig. 2) .
Pathological analysis of spinal cord
The lumbar spinal cords of the mice were examined by Nissl staining for neurons as well as by GFAP immunohistochemical staining for astrocytes. These data confirmed that the presence of the Mobr allele prolonged the lives of the SOD1 G86R mice by inhibiting spinal cord pathology. Neuronal cell density in the ventral horn of the lumbar spinal cord enlargement in 125-d-old males hemizygous for Mobr (without SOD1 G86R ) was similar to presymptomatic Mobr/SOD1 G86R males of the same age (Fig. 3,  compare A, E and D, H ); however, symptomatic male SOD1 G86R mice of the same age exhibited a conspicuous loss of neurons in the ventral horn (Fig. 3 B, F ) . Older Mobr/SOD1 G86R male mice developed conspicuous neuronal loss after becoming symptomatic (156 d) (Fig. 3C,G) .
GFAP immunoreactivity indicated a parallel astrocytosis in association with neuronal cell loss. In non-Tg Mobr mice (Fig.  3I ) and presymptomatic Mobr/SOD1 G86R mice (Fig. 3L ), little GFAP immunoreactivity was apparent, whereas symptomatic SOD1 G86R animals with or without the Mobr allele exhibited pronounced GFAP staining in the ventral horn (Fig. 3 J, K ).
SOD1 levels and activity
Western blot confirmed that SOD1 was overexpressed in the brains and spinal cords of the SOD1 G86R transgenic mice, and that despite lower copper levels, the Mobr allele has no effect on the SOD1 expression levels in these tissues (Fig. 4 A) . Calibrated densitometry of Western blots indicated that SOD1 levels were 84% higher in SOD1 G86R transgenic mice compared with nontransgenic controls, and expression of SOD1 was 25% higher in spinal cord than in brain (Fig. 4 A) . Because the SOD1 G86R mutation abolishes SOD activity (Ripps et al., 1995) , we confirmed that overexpression of the mutant transgene did not increase SOD1 activity in the SOD1 G86R mice using SOD activity gels (Fig.  4 B) and spectrophotometric assays (Fig. 4C ).
Discussion
Our study confirms that systemic copper deficiency (induced on this occasion by a selective genetic lesion) significantly delays motor neuron degeneration in a mutant SOD1 transgenic mouse model of FALS.
Tissue culture studies have shown that copper chelation ameliorates the cytotoxic effects of transfected mutant SOD1 (Wiedau-Pazos et al., 1996 ). An increase in copper in erythro- G86R females on hybrid C57BL/6 ϫ FVB/N background) were compared with age-matched (3 months old) SOD1 G86R transgenic mice. SOD1 G86R transgenic mice were on an FVB/N background, and copper levels were also compared with age-matched nontransgenic (Non-Tg) mice on the same background, nontransgenic controls possessing the same hybrid background as the Mobr/SOD1 G86R mice, and nontransgenic mice possessing the Mobr allele on the hybrid background (hyb ϭ C57BL/6 ϫ FVB/N). Values are means Ϯ SD; n Ն3 mice; **p Ͻ 0.001. G86R transgenic mice. The Kaplan-Meier cumulative survival plot shows the cumulative probability of survival of Mobr/ SOD1 G86R mice (n ϭ 33), compared with SOD1 G86R without Mobr (n ϭ 44) (males and females pooled) both in the same background (hyb ϭ C57BL/6 ϫ FVB/N). There is a significant increase in survival in genetically copper deficient Mobr/SOD1 G86R mice ( p ϭ 0.007; by Mantel-Cox rank test).
cytes of the ALS patients has been reported with at least two SOD1 mutations (G37R and H46R) (Ogawa et al., 1997) . These findings support the notion that SOD1 mutations linked to ALS exert their damaging effect in vivo through altered chemistry of Cu 2ϩ bound to SOD1. It has been suggested previously that the Cu 2ϩ could react with nitric oxide and superoxide in the cell to form highly reactive peroxynitrite (Beckman et al., 1993) . Increased Cu 2ϩ -mediated peroxidase activity of mutant SOD1 in comparison with wildtype SOD1 has also been reported (M. B. Yim et al., 1996 ; H. S. Yim et al., 1997) . Cu 2ϩ -mediated oxidation also has been proposed to be pathogenic by causing misfolding and aggregation of mutant SOD1 (Rakhit et al., 2002) .
The copper deficiency brought about by the Mobr allele induced a slightly greater prolongation of life span than treatment of the same mouse model with oral administration of a copper chelating drug (D-penicillamine) (Hottinger et al., 1997) . Similarly, treatment of transgenic SOD1 G93A mice with trientine also delayed significantly the onset of neurological signs (Nagano et al., 1999) , but neither intervention completely rescued the lethal phenotype. Although the 9% increase in life span induced by the Mobr allele that we observed is modest, one must consider that the Cu depletion genetically induced by the Mobr (Menkes disease) lesion is life threatening. Therefore, it is very surprising that animals doubly mutant for two pathogenic mutations (copper depletion plus mutant SOD1) live significantly longer than the single SOD1 mutant mice (controlled for genetic background). This means that the condition of the SOD1 G86R mouse, which usually dies within 5 months of birth, is improved by the additional presence of severe systemic copper deficiency. This is important evidence supporting a role for copper in this disease state.
Although our results are encouraging, it is possible that tissue copper levels cannot be lowered sufficiently by this genetic lesion to prevent pathogenic interaction of tissue Cu with mutant SOD1. Oxidative damage could be caused by rogue catalytic reactive oxygen species production derived from a minor fraction of SOD1. The Mobr mice still have plenty of Cu in their tissues, and multiple and redundant pathways transport Cu within the cytosol. Therefore, it may be difficult to induce sufficient copper deficiency by any genetic lesion (or even by chelation therapy) to prevent some degree of Cu interaction with SOD1 without totally ablating tissue Cu, which is not a viable strategy. Therefore, potential drug therapy would need to specifically target Cu interaction in mutant SOD1 rather than induce total tissue Cu depletion.
An interesting feature of our findings is that mean survival is extended, but the death rate, once symptoms appear, is unaltered. A similar finding was made when B-cell lymphoma/leukemia-2 transgenes were overexpressed in a mouse model of FALS (Kostic et al., 1997) . This suggests that the natural history of the disease may have two distinct phases: a prodromal phase during which the biochemical lesion (e.g., SOD1 aggregation, mitochondrial damage) accumulates to a critical concentration threshold, followed by a propagation phase during which neuronal demise and the lethal phenotype occur. In this case, the biochemical forces that induce SOD1 aggregation might not be the same as those that then propagate tissue damage. Cu depletion may inhibit the onset of the disease, perhaps by decreasing the rate of oxidationmediated SOD1 aggregate formation (Rakhit et al., 2002) ; however, Cu may not necessarily contribute to the damage induced by the aggregates themselves, once they are formed. Subramaniam et al. (2002) reported that genetic ablation of CCS did not significantly rescue the ALS phenotype in mutant SOD1 transgenic animals (G93A, G85R, and G37R). CCS promotes the insertion of Cu 2ϩ into the active site of SOD1, and these findings were widely taken to imply that Cu 2ϩ could be excluded from the pathophysiology of the FALS phenotype in this model. The data of Subramaniam et al. (2002) label. Where did the rest of the radiolabel go? The answer is probably that the samples were homogenized in EDTA and bathocuproine, high-affinity Cu chelators, which would have stripped all but the highest affinity binding of 64 Cu from the proteins of the samples.
64 Cu binding to lower-affinity Cu binding sites on SOD1 would not have survived this procedure, and therefore no conclusion about the total stoichiometry of Cu binding to SOD1 can be made from these results. The marked decrease in dismutase activity that was observed in the CCS Ϫ/Ϫ / mutant SOD1 mice does not indicate that total Cu binding to SOD1 is decreased, because this activity is only a reflection of Cu binding at the high-affinity, active site; the dismutase activity assay does not reflect Cu bound to other sites on SOD1.
Indeed, Goto et al. (2000) have reported that in the absence of CCS, copper binds abnormally to SOD1, which increases the possibility that it would foster abnormal redox activity.
A recent publication demonstrated a mechanism responsible for CCS-independent activation of mammalian SOD1 that could bind Cu 2ϩ using reduced glutathione in both yeast and murine cells null for CCS. (Carroll et al., 2004) . SOD1 has also been identified in mitochondria inner membranous space (Higgins et al., 2002; Mattiazzi et al., 2002) . How mitochondrial SOD1 obtains copper and zinc is not clear, because SOD1 has no sequence tag for importation into mitochondria and would need to be unfolded before it could cross the mitochondrial lipid bilayer.
Because abnormalities in mitochondrial morphology and function occur as a prelude to motor neuron death (Kong and Xu, 1998) , it is possible that SOD1 within the mitochondria may be critical to the pathogenesis of ALS. Together, our findings indicate that Cu 2ϩ interaction with mutant SOD1 still appears to play an important role in the etiopathogenesis of FALS. G86R transgenic mice and non-Tg (FVB/N) controls measured by spectrophotometric assay and expressed as percentage of control (n ϭ 6 for each group). There was no significant difference between these groups.
